Post by The Global Fund

Great news: A major step forward in the fight against tuberculosis (TB), the world’s deadliest infectious disease. Today, thirteen countries are preparing to roll out a new generation of near-point-of-care (NPOC) molecular diagnostic tests for TB, bringing fast, accurate diagnosis directly to primary care facilities and remote communities. With support from Children's Investment Fund Foundation (CIFF) and implemented on-the-ground by The Aurum Institute Institute, this Early Adopter initiative driven by The Global Fund will deliver nearly 3 million NPOC TB tests across Bangladesh, Benin, Cameroon, Ethiopia, Indonesia, Kenya, Nigeria, Peru, the Philippines, South Africa, Uganda, Viet Nam and Zambia. These small, lightweight, simple-to-use NPOC tests deliver results in under an hour and can help reduce case-finding costs, increase equity and expand access to rapid diagnosis for people who struggle to produce sputum, including people living with HIV. “By bringing accurate diagnosis closer to communities, we can find people earlier, reduce transmission and close the diagnostic gap that has slowed progress for too long.” Peter Sands, Executive Director of the Global Fund Learn more: https://lnkd.in/e_EB6Yh8